BioAptagen

Guwahati, India Founded: 2019 • Age: 7 yrs
Develops innovative diagnostic kits for detecting disease cells in biological fluids.

About BioAptagen

BioAptagen was a Healthcare company based in Guwahati (India) founded in 2019 by Swapnil Sinha and Shubhangi Kaushik. It develops innovative diagnostic kits for detecting disease cells in biological fluids. It operates on a B2B model. Its chief executive, as recorded, is Swapnil Sinha. Its Indian entity Altanostics Labs Private Limited reported revenue of β‚Ή13.1 Lakh. The company is recorded as dissolved. Its focus areas include Biotechnology, Diagnostics and Cell Detection.

Company details

BioAptagen develops innovative diagnostic kits for detecting disease cells in biological fluids through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and cell detection. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹13.1 Lakh

    FY 2022 · +8% YoY

  • Net Profit
    ₹4.7 Lakh

    FY 2022 · 36% margin

  • EBITDA
    ₹6.4 Lakh

    FY 2022 · 48% margin

Board of directors of Altanostics Labs Private Limited (BioAptagen)

Altanostics Labs Private Limited is the primary company behind BioAptagen. The board of Altanostics Labs Private Limited currently have 2 directors; the longest-serving is Thiruneelakantan Srinath, appointed in 2022. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Thiruneelakantan Srinath
DIN 07988037
Director04 Apr 20224 yrs 7 moAltanostics Labs Private Limited
Aakriti Garg
DIN 10798476
Director07 Oct 20242 yrs 1 moAltanostics Labs Private Limited

People of BioAptagen

2 people are tracked at BioAptagen (2 in leadership).

NameRoleGroup
Co-Founder, CEOLeadership
Co-FounderLeadership
Premium access

Complete people profiles for BioAptagen

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of BioAptagen

Figures of Altanostics Labs Private Limited, the primary company behind BioAptagen, for FY 2022. Revenue was ₹13.1 Lakh (+8% year on year). Net profit was ₹4.7 Lakh (36% margin). EBITDA was ₹6.4 Lakh (48% margin). Revenue has grown at a compounded annual rate of +51% over three years.

  • ₹13.1 LakhRevenue · FY 2022 · +8% YoY
  • ₹4.7 LakhNet profit · 36% margin
  • ₹6.4 LakhEBITDA · 48% margin
  • ₹1 LakhPaid-up capital
  • +51%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Altanostics Labs Private Limited are on its company page.

Premium access

Detailed financial statements for BioAptagen

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioAptagen

BioAptagen was founded in 2019.

BioAptagen is headquartered in Guwahati, India. It is registered at Guwahati, Assam, India.

Swapnil Sinha is the CEO of BioAptagen, as recorded in our data. They have also founded this company.

The primary company behind BioAptagen, Altanostics Labs Private Limited, reported revenue of β‚Ή13.1 Lakh for FY 2022, up 8% year on year.

BioAptagen develops innovative diagnostic kits for detecting disease cells in biological fluids through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and cell detection. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

BioAptagen operates through Altanostics Labs Private Limited.

The legal entities of BioAptagen currently have 2 directors, including Aakriti Garg, Thiruneelakantan Srinath.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available